tirzepatide medication class Patients who took the anti-obesity drug for almost two years lost 25 percent of their body weight and maintained improvements in metabolic and cardiovascular health, according to a new phase 3 Tirzepatide Dosing - A Patient

Type 1 diabetes requires insulin therapy because the body no longer produces insulin on its own

Klinic offers continuous support, including telehealth consultations and follow-ups

Landmark trials like SUSTAIN-6 and LEADER found that semaglutide caused symptomatic hypoglycemia in fewer than 5% of participants using the medication alone, but rates exceeded 20% in subgroups taking insulin concurrently

Companies are rarely transparent with patients or the public about the medical groups behind the screens

Now, an even more successful GLP-1, Mounjaro, is available in New Zealand, but at about $800 a month, Janet is tapping out of her experiment with GLP-1s

While this does not typically cause weight plateaus, the associated symptoms like anxiety, insomnia, and digestive changes can interfere with your meal planning and dietary compliance